Search

everythinglearnresearchcommunity

for

Search:↓

Improving mesenchymal stromal cell therapies requires overcoming cell death and optimizing delivery methods.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

3D bioprinting offers new ways to treat head and neck defects with bioinks that mimic natural tissues.

PRP shows promise in treating joint and spine issues, but translating lab results to humans is challenging.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Citrullinated proteins from Porphyromonas gingivalis may contribute to rheumatoid arthritis.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Melatonin, a hormone, can help protect skin from aging by reducing stress, inflammation, and damage, and may also help treat hair loss in women.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

An integrated approach can help treat childhood alopecia areata.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

Effective treatments for severe alopecia areata are still lacking.

New treatments for epidermolysis bullosa show promise in improving patients' lives, but a cure is still not available.

A wearable device using NIR light may help treat hair loss non-invasively.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

More research is needed to understand and manage rheumatoid arthritis better.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Histone modification is key in treating chronic inflammatory skin diseases.